The statement has been issued following confusion surrounding the recommended targets in the JBS2 Guideline. JBS2 recommends that Total Cholesterol is treated to 4mmol/L and Low-Density Lipoprotein is treated to 2mmol/L.
The statement clarifies that current National Policy is that Total Cholesterol (TC) is treated to 5mmol/L and Low-Density Lipoprotein Cholesterol (LDL-C) is treated to 3mmol/L as determined by the National Service Framework (NSF) for Coronary Heart Disease (CHD). These targets may be revised upon completion of NICE Lipid Modification Guideline due in December 2007.
It is further clarified that the Quality and Outcomes Framework cholesterol target will remain at 5mmol/L for 2007/08 and that the Healthcare Commission will assess delivery of the current NSF and NICE guidance and not JBS2.
Action: Primary and Secondary prevention of CHD involving the prescribing of statins should being with Simvastatin 40mg. Treatment should aim to achieve TC below 5mmol/L and LDL-C below 3mmol/L.
|« Comparative bisphosphonate study||Varenicline review »|